Nimble Therapeutics spins out of Roche, saving Madison jobs

Nimble Therapeutics formed in April, spun out of Roche Sequencing Solutions, originally NimbleGen Systems, which is slated to close by June 2020. NimbleGen, born from UW-Madison research in 1999, discovered a fast, inexpensive way to manufacture DNA microarrays, also called gene chips. Gene chips are tiny test platforms used to explore genetic differences. The microarrays produced in Madison are used to better characterize the genetic aberrations in cancerous tumors.

Read the full article at: